Genetics Quiz: Two Hit Hypothesis

What this quiz covers

This quiz focuses on Two Hit Hypothesis, giving you a quick way to practice the rules, question types, and explanations that matter most for Genetics.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. The inherited mutant TP53 allele increases the somatic mutation rate, making the second hit, and thus cancer, appear dominant in the pedigree.
2. The predisposition is dominant because every cell has inherited one inactive allele, making the probability of a second somatic hit in at least one cell over a lifetime extremely high. (correct answer)
3. TP53 is an exception to the two-hit hypothesis; it functions as a dominant gene at both the cellular and organismal levels, requiring only one mutation.
4. The dominant inheritance pattern is an artifact of environmental factors that are shared within the family and are required to trigger the second hit.

Explanation: The key distinction is between the genetics of the predisposition and the genetics of the cancer cell itself. The predisposition is inherited as a dominant trait because inheriting one mutant allele makes cancer highly probable (high penetrance). However, a cell only becomes cancerous after the second, wild-type allele is also lost or mutated (the 'second hit'), meaning the gene is recessive at the cellular level.

Question 2

1. Gatekeepers repair DNA, so losing both copies allows mutations to accumulate rapidly, which constitutes the two hits.
2. Gatekeepers control blood vessel formation, so losing both copies allows the tumor to build its own blood supply.
3. Gatekeepers are transcription factors that require dimerization, so one mutant copy is enough to inactivate the protein (one-hit model).
4. Gatekeepers directly inhibit cell cycle progression or promote apoptosis; losing both copies removes a primary brake on cell division. (correct answer)

Explanation: When you encounter questions about tumor suppressor genes, focus on understanding the fundamental difference between "gatekeepers" and "caretakers" and how this relates to cancer development mechanisms. Gatekeeper genes like RB1 function as direct controllers of cell division—they act as molecular brakes that either halt the cell cycle at checkpoints or trigger apoptosis when cells become damaged or abnormal. The two-hit hypothesis perfectly describes how these genes work: since you inherit two copies of each gene, losing just one copy still leaves the other functional copy to maintain control over cell division. However, when both copies are lost or mutated (the "two hits"), the cell loses this critical brake system entirely, allowing uncontrolled proliferation that can lead to cancer. Option A confuses gatekeepers with caretakers—caretaker genes are the ones responsible for DNA repair. Option B describes angiogenesis factors, not tumor suppressors. Option C incorrectly suggests a dominant-negative effect, which would actually support a one-hit model rather than the two-hit hypothesis that characterizes gatekeeper genes. Option D correctly identifies that gatekeepers directly control cell cycle progression and apoptosis, and that losing both functional copies removes the primary mechanism preventing uncontrolled cell division. Remember this key distinction: gatekeepers are the "direct brake pedal" on cell division, while caretakers are the "maintenance crew" that fixes DNA damage. The two-hit model applies to gatekeepers because you need to lose both brakes before the car (cell) goes out of control.

Question 3

1. Finding that the 'second hit' is frequently an epigenetic silencing event rather than a DNA mutation.
2. Identifying a family where the predisposition to the cancer is inherited in an autosomal recessive pattern.
3. Observing that the age of cancer onset for individuals with germline mutations varies significantly.
4. Discovering that tumor cells from patients with germline mutations consistently show high expression of the remaining wild-type allele. (correct answer)

Explanation: When evaluating challenges to the classic two-hit hypothesis, you need to understand its core prediction: tumor suppressor genes require inactivation of both alleles to lose function and promote cancer. The first hit (often germline) inactivates one copy, while the second hit eliminates the remaining functional allele. Answer D poses the most direct challenge because it contradicts the fundamental mechanism. If tumor cells "consistently show high expression of the remaining wild-type allele," this means the second allele is not only intact but actively producing protein. This directly violates the two-hit model, which requires both copies to be nonfunctional for cancer to develop. Answer A is actually consistent with the two-hit hypothesis. Epigenetic silencing effectively inactivates genes just like DNA mutations do—the mechanism of the second hit doesn't matter, only that it occurs. Answer B also supports the model, as autosomal recessive inheritance patterns align perfectly with needing two defective alleles for disease manifestation. Answer C describes variable penetrance or expressivity, which is common in cancer genetics and doesn't challenge the core two-hit mechanism—it just reflects the complexity of cancer development beyond the initial tumor suppressor loss. The key strategy here is distinguishing between findings that modify details of the two-hit hypothesis versus those that fundamentally contradict it. Look for scenarios where both alleles should be inactive according to the model, but experimental evidence shows otherwise.

Question 4

1. The tumor cells have lost both BRCA1/2 alleles (two hits) and are uniquely reliant on the PARP enzyme for DNA repair; inhibiting PARP causes synthetic lethality. (correct answer)
2. The PARP inhibitor reactivates the lost BRCA1/2 gene, restoring normal function and serving as a form of gene therapy.
3. The germline BRCA1/2 mutation (first hit) makes all cells in the body, including cancer cells, hypersensitive to the DNA damage caused by PARP inhibitors.
4. PARP inhibitors can only function by binding to the mutant BRCA1/2 protein, which is present in tumor cells but not normal cells.

Explanation: This question tests your understanding of synthetic lethality—a powerful concept where the combination of two genetic defects is lethal to a cell, even though each defect alone might be survivable. PARP inhibitors work through synthetic lethality in BRCA-deficient tumors. Here's the logic: BRCA1/2 proteins are essential for homologous recombination, a high-fidelity DNA repair pathway. In hereditary BRCA cancers, tumor cells have lost both BRCA alleles (following Knudson's two-hit hypothesis), leaving them unable to perform this crucial repair function. These cells compensate by relying heavily on alternative repair pathways, including base excision repair, which depends on the PARP enzyme. When you inhibit PARP in BRCA-deficient cells, you eliminate their backup repair mechanism, causing accumulation of DNA damage and cell death. Normal cells, which still have functional BRCA proteins, can survive PARP inhibition because they retain homologous recombination capability. Choice A correctly describes this synthetic lethal relationship. Choice B is wrong because PARP inhibitors don't restore BRCA function—they're enzyme inhibitors, not gene therapy. Choice C misunderstands the mechanism; the germline mutation alone (first hit) doesn't make cells hypersensitive—it's the complete loss of BRCA function in tumor cells that creates vulnerability. Choice D incorrectly suggests PARP inhibitors bind to BRCA proteins; they actually inhibit the PARP enzyme directly. Remember: synthetic lethality exploits vulnerabilities created by cancer-specific genetic defects, allowing targeted therapy that preferentially kills tumor cells while sparing normal tissue.

Question 5

1. Both the first and second hits were somatic events that occurred sequentially in a single cell lineage. (correct answer)
2. The first hit was a germline mutation with very low penetrance, and the second hit was somatic.
3. The patient is a somatic mosaic for the first hit, which occurred early in development, and the second hit was also somatic.
4. The first hit was inherited from a parent, but the parent was protected by a modifier gene that is absent in the patient.

Explanation: When you encounter a tumor suppressor gene question, focus on Knudson's two-hit hypothesis: both copies of a tumor suppressor gene must be inactivated for cancer to develop. The key is determining whether hits are germline (inherited) or somatic (acquired during lifetime). The clinical presentation provides crucial clues. This patient has no family history of cancer and developed the tumor late in life. If either hit were germline, you'd expect earlier onset and often a family history, since germline mutations are present in every cell from birth, making the second hit more likely to occur sooner. Since both hits occurred somatically in the same cell lineage, this explains the late onset - it takes time for two independent mutational events to occur in the same cell. The lack of family history makes sense because neither parent carried a germline mutation to pass down. Option B is incorrect because a germline first hit, even with low penetrance, would likely manifest earlier and show some family pattern. Option C describes mosaicism, but early developmental mutations affecting multiple cells would still likely cause earlier onset than pure somatic events. Option D suggests an inherited mutation with modifier gene protection, but this doesn't align with the complete absence of family history. Study tip: For tumor suppressor genetics questions, always correlate the clinical presentation with mutation timing. Germline hits = early onset + family history. Pure somatic hits = later onset + no family history. This pattern recognition will serve you well on genetics exams.

Question 6

1. A hereditary case where the inherited mutation was missed by the blood test because it is a complex rearrangement.
2. A sporadic case resulting from two independent somatic events: a point mutation and a subsequent chromosomal loss. (correct answer)
3. A case of somatic mosaicism, where the first hit occurred post-zygotically and was therefore not present in blood lymphocytes.
4. A non-genetic case caused by a viral infection of the retina that mimics the phenotype of RB1 loss.

Explanation: The absence of the mutation in blood DNA indicates it is not a germline event. The presence of two 'hits' (a mutation and LOH) only in the tumor is the definition of a sporadic cancer according to the two-hit hypothesis. Later onset (age 4) and unilateral presentation are also characteristic of sporadic cases. While somatic mosaicism (C) is a possibility, the most straightforward and common explanation is a classic sporadic tumor.

Question 7

1. It fully supports the classic hypothesis, as a second somatic hit to delete the wild-type allele is still strictly required for any effect on the cell.
2. It converts TP53 into a proto-oncogene, where the single dominant-negative mutation is a sufficient gain-of-function event for transformation.
3. It bypasses the need for a 'second hit' because the first mutational event functionally cripples the protein from the wild-type allele, creating a state similar to biallelic loss. (correct answer)
4. It requires three hits for tumorigenesis: the inherited dominant-negative mutation, a somatic hit on the other allele, and a mutation in a downstream target.

Explanation: A dominant-negative mutation is a significant modification to the simple two-hit loss-of-function model. The first hit does more than just remove one functional copy; it actively poisons the protein produced from the remaining wild-type allele. This means a single heterozygous mutation can severely impair the tumor suppressor pathway, behaving phenotypically as if two hits have occurred, thus accelerating tumorigenesis without necessarily requiring a physical loss of the second allele.

Question 8

1. Hereditary cases require only a single germline mutation for tumor formation, while sporadic cases require two somatic mutations.
2. In hereditary cases, one activating mutation is inherited and a second is acquired somatically; in sporadic cases, two activating mutations are acquired somatically.
3. Hereditary cases result from an inherited mutation followed by a somatic mutation in a second, different tumor suppressor gene, while sporadic cases involve two mutations in the same gene.
4. In hereditary cases, one inactivating mutation is inherited via the germline and a second is acquired somatically; in sporadic cases, two inactivating mutations are acquired somatically in the same cell lineage. (correct answer)

Explanation: The two-hit hypothesis posits that for tumor suppressor genes like RB1, both alleles must be inactivated. In hereditary cases, the 'first hit' is a germline mutation present in all cells, and the 'second hit' is a somatic mutation in the remaining wild-type allele. In sporadic cases, both 'hits' are separate somatic mutation events that must occur in the same cell.

Question 9

1. Two independent somatic mutations occurred in a single cell in the right eye, and two different independent somatic mutations occurred in a single cell in the left eye.
2. The child inherited a germline mutation in one RB1 allele and subsequently sustained a single somatic mutation in the remaining wild-type allele in retinal cells of both eyes. (correct answer)
3. The child inherited a single germline mutation in RB1 which was sufficient on its own to cause tumors to form in both eyes without requiring a second hit.
4. The child was exposed to a potent mutagen in utero that caused simultaneous somatic mutations in the RB1 gene in both developing retinas.

Explanation: Early onset and bilateral tumors are the classic signs of hereditary retinoblastoma. The most logical explanation is a germline mutation ('first hit') present in all cells. This dramatically increases the likelihood that a 'second hit' (a somatic mutation) will occur independently in each eye, leading to multiple tumors at an early age. The probability of two separate sporadic tumors developing (A) is astronomically low.

Question 10

1. In haploinsufficiency, the loss of a single allele is sufficient to drive the full cancerous phenotype, and a second hit never occurs.
2. Haploinsufficiency requires one genetic hit and one epigenetic hit, whereas the classic model requires two genetic hits.
3. In haploinsufficiency, the protein from the single mutant allele actively interferes with the wild-type protein, a dominant-negative effect.
4. In haploinsufficiency, the reduction to 50% of the gene's protein product is itself enough to disrupt normal cellular function and promote tumorigenesis, even before a second hit. (correct answer)

Explanation: Haploinsufficiency means that a single functional copy of a gene is not enough to maintain the normal state. For a haploinsufficient TSG, losing one allele (the first hit) already creates a pro-tumorigenic cellular environment because 50% of the protein is not enough to perform the tumor-suppressing function adequately. A second hit may still occur and often does, but the initial loss is not silent as it is in the classic model.

Question 11

1. The first hit in a hereditary case is a germline mutation present in all cells, while the first hit in a sporadic case is a somatic mutation present only in a single cell. (correct answer)
2. The first hit in a hereditary case is typically a large deletion, while the first hit in a sporadic case is usually a point mutation.
3. The first hit in a hereditary case does not provide a growth advantage, while the first hit in a sporadic case immediately causes clonal expansion.
4. There is no functional difference; in both scenarios, the first hit inactivates one allele of a tumor suppressor gene.

Explanation: While the molecular effect on the single cell might be the same (loss of one functional allele), the most significant difference is its distribution in the organism. In hereditary cancer, the first hit is a germline event, meaning every cell in the body starts with one non-functional allele, putting millions of cells at risk for the second hit. In sporadic cancer, the first hit is a somatic event, occurring in just one cell, which must then also acquire the second hit.

Question 12

1. The inherited germline mutation destabilizes the genome, causing the rate of somatic mutation for the second hit to increase dramatically.
2. The probability of one somatic event occurring in any of millions of cells is vastly greater than the probability of two specific, rare somatic events occurring in the same single cell. (correct answer)
3. The first somatic hit in a sporadic case takes significantly longer to acquire than the second somatic hit, delaying the onset of the tumor.
4. Individuals with a germline mutation are often exposed to more environmental mutagens, which accelerates the timing of the second hit.

Explanation: This question addresses the core probability of the hypothesis. In the hereditary case, every target cell already has one hit. The tumor forms as soon as any one of these millions of cells acquires a second hit. The probability of this single event happening somewhere is high. In the sporadic case, two independent, rare events must occur in the same cell, the probability of which is the product of two very small probabilities (e.g., p1 * p2), making it a much rarer and later event.

Question 13

1. Hereditary risk (\approx 1 - (1 - 10^{-6})^{10^7}), which is near 1. Sporadic risk requires two hits in one cell, with probability (\approx 10^7 \times (10^{-6} + 10^{-6})).
2. Hereditary risk is high because the germline mutation increases the somatic mutation rate to (\approx 10^{-2}). Sporadic risk remains low at (10^{-6}).
3. Hereditary risk is high because any of the (10^7) cells needs only one hit (probability (\approx 10^7 \times 10^{-6})). Sporadic risk requires two hits in the same cell (probability (\propto (10^{-6})^2)). (correct answer)
4. Hereditary risk and sporadic risk are both low, but hereditary risk is slightly higher because the first hit is guaranteed at birth.

Explanation: This question requires applying probabilistic reasoning. In the hereditary case, the probability of a second hit is the rate of one mutation multiplied by the large number of target cells. Since (10^7 \times 10^{-6} = 10), it is statistically almost certain to happen. In the sporadic case, the probability of two independent mutations occurring in the same cell is proportional to the square of the single-mutation rate, ((10^{-6})^2 = 10^{-12}), an exceedingly rare event, even when considering the total number of cells.

Question 14

1. A new, independent point mutation that coincidentally matches the inherited mutation occurred on the other chromosome.
2. Nondisjunction of the RB1-carrying chromosome, resulting in the loss of the chromosome with the wild-type allele.
3. Mitotic recombination between the two homologous chromosomes, followed by a segregation pattern that yields a daughter cell with two copies of the mutant allele. (correct answer)
4. Large-scale deletion of the chromosomal arm containing the wild-type RB1 allele.

Explanation: For a cell to become homozygous for a pre-existing mutation, the genetic information from the mutant chromosome must be copied over to the wild-type chromosome, or segregation must result in two mutant copies. Mitotic recombination can lead to a daughter cell that is homozygous for all genes distal to the crossover point. Nondisjunction or deletion (B and D) would result in hemizygosity (only one copy of the gene), not homozygosity. A new identical mutation (A) is theoretically possible but statistically far less likely than mitotic recombination or gene conversion.

Question 15

1. It is an extension of the hypothesis, where the development of the cancer requires satisfying the 'two-hit' requirement for multiple different tumor suppressor genes over time. (correct answer)
2. It invalidates the two-hit hypothesis, demonstrating that cancer is a result of single hits in many different genes rather than two hits in one gene.
3. It is unrelated, as the two-hit hypothesis applies only to hereditary cancers, while the multi-step model applies only to sporadic cancers.
4. It suggests the 'first hit' is always in APC, and the 'second hit' can be a mutation in any other cancer-associated gene like KRAS or TP53.

Explanation: The multi-step model of colon cancer is not a rejection of the two-hit hypothesis but an expansion of it. The initial event is often the biallelic inactivation of the APC gene (satisfying the two-hit requirement for that gatekeeper). This initiates the polyp, but for progression to carcinoma, additional mutations are needed, including the activation of an oncogene (KRAS) and the inactivation of another tumor suppressor (TP53), which would also require two hits.

Question 16

1. TSGs require two loss-of-function mutations, whereas proto-oncogenes also require two mutations, but they must be gain-of-function.
2. TSGs typically require two inactivating events to promote cancer, acting recessively, while proto-oncogenes typically require only one activating event, acting dominantly. (correct answer)
3. Mutations in TSGs are always inherited through the germline, while mutations that activate proto-oncogenes are exclusively somatic events.
4. Inactivation of TSGs leads to uncontrolled cell death, while activation of proto-oncogenes leads to uncontrolled cell proliferation.

Explanation: This question tests the core distinction between these two classes of cancer genes. The two-hit hypothesis applies to TSGs, which act as cellular 'brakes'; both copies must be lost to release the brake (recessive mechanism). Proto-oncogenes are 'accelerators'; a single gain-of-function mutation can cause the protein to become constitutively active, driving cell proliferation (dominant mechanism).

Question 17

1. The presence of both the germline mutant allele and the wild-type allele, with the wild-type allele being silenced by promoter hypermethylation.
2. The presence of the germline mutant allele and a new, different somatic mutation on the other allele, resulting in compound heterozygosity.
3. The exclusive presence of the germline mutant allele and the complete absence of the wild-type allele's DNA sequence. (correct answer)
4. The presence of only the wild-type allele, indicating the cell with the germline mutation was eliminated via apoptosis.

Explanation: Loss of heterozygosity (LOH) is a common mechanism for the second hit. In this scenario, the patient's normal cells are heterozygous (mutant/wild-type). If the tumor cell has lost the chromosome segment containing the wild-type allele, only the mutant allele will remain. This finding of homozygosity or hemizygosity for the mutant allele in the tumor, compared to heterozygosity in normal tissue, is the hallmark of LOH.

Question 18

1. A new, independent point mutation that coincidentally matches the inherited mutation occurred on the other chromosome.
2. Nondisjunction of the RB1-carrying chromosome, resulting in the loss of the chromosome with the wild-type allele.
3. Mitotic recombination between the two homologous chromosomes, followed by a segregation pattern that yields a daughter cell with two copies of the mutant allele. (correct answer)
4. Large-scale deletion of the chromosomal arm containing the wild-type RB1 allele.

Explanation: For a cell to become homozygous for a pre-existing mutation, the genetic information from the mutant chromosome must be copied over to the wild-type chromosome, or segregation must result in two mutant copies. Mitotic recombination can lead to a daughter cell that is homozygous for all genes distal to the crossover point. Nondisjunction or deletion (B and D) would result in hemizygosity (only one copy of the gene), not homozygosity. A new identical mutation (A) is theoretically possible but statistically far less likely than mitotic recombination or gene conversion.

Question 19

1. In haploinsufficiency, the loss of a single allele is sufficient to drive the full cancerous phenotype, and a second hit never occurs.
2. Haploinsufficiency requires one genetic hit and one epigenetic hit, whereas the classic model requires two genetic hits.
3. In haploinsufficiency, the protein from the single mutant allele actively interferes with the wild-type protein, a dominant-negative effect.
4. In haploinsufficiency, the reduction to 50% of the gene's protein product is itself enough to disrupt normal cellular function and promote tumorigenesis, even before a second hit. (correct answer)

Explanation: Haploinsufficiency means that a single functional copy of a gene is not enough to maintain the normal state. For a haploinsufficient TSG, losing one allele (the first hit) already creates a pro-tumorigenic cellular environment because 50% of the protein is not enough to perform the tumor-suppressing function adequately. A second hit may still occur and often does, but the initial loss is not silent as it is in the classic model.

Question 20

1. One inherited mutation in BLS1 and one acquired somatic mutation in the same gene within the tumor cells.
2. A single, activating point mutation in the BLS1 gene found only in the tumor cells, not in normal tissue.
3. The presence of two distinct, inactivating somatic mutations or one mutation coupled with LOH of the other allele, found only within the tumor cells. (correct answer)
4. Gross amplification of the BLS1 locus, leading to significant overexpression of the BLS1 protein in tumor cells.

Explanation: For a sporadic cancer driven by a TSG, the two-hit hypothesis predicts that both hits must be somatic and must occur in the tumor lineage. Therefore, the tumor cells would show biallelic (both alleles) inactivation of BLS1, while the patient's normal, germline DNA would have two functional copies. This inactivation can occur through two separate mutations or, more commonly, one mutation followed by loss of the other allele (LOH).